2017
DOI: 10.1016/j.jtho.2017.09.1563
|View full text |Cite
|
Sign up to set email alerts
|

P3.02-033 Pathological and Molecular Alterations after First and Second Generation EGFR-TKI Therapy in Patients with EGFR-Mutated Lung Adenocarcinomas

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles